Neonc Technologies Holdings (NTHI) Cash from Operations (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Cash from Operations of 6991773.0 for Q1 2026, down 23.75% year-over-year from 9169176.41 in Q1 2025, and down 94.69% quarter-over-quarter from 3591171.0 in Q4 2025.
Neonc Technologies Holdings (NTHI) Cash from Operations (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Cash from Operations for 3 consecutive years, with 6991773.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations fell 23.75% year-over-year to 6991773.0; the TTM figure through Mar 2026 stood at 21705666.0 (down 116.85% YoY), while the FY2025 annual figure was 20363948.0, down 383.25% from the prior year.
- Cash from Operations declined to 6991773.0 in Q1 2026 per NTHI's latest filing, from 3591171.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 145747.0 in Q1 2024 and bottomed at 6991773.0 in Q1 2026.
- Historically, Cash from Operations has averaged 3507737.44 across 3 years, with a median of 3591171.0 in 2025.
- Annual changes were most pronounced in 2025 — Cash from Operations slumped 3976.62% — and 2026, when it decreased 23.75%.
- Neonc Technologies Holdings' Cash from Operations stood at 954404.0 in 2024, then tumbled by 276.27% to 3591171.0 in 2025, then tumbled by 94.69% to 6991773.0 in 2026.
- Business Quant data shows NTHI's Cash from Operations at 6991773.0 in Q1 2026, 3591171.0 in Q4 2025, and 5808551.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | -4.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.77 Mn |
| Jun 30, 2026 | -4.77 Mn |
| Mar 31, 2026 | -6.99 Mn |
| Mar 31, 2026 | -6.99 Mn |
| Dec 31, 2025 | -3.59 Mn |
| Dec 31, 2025 | -3.59 Mn |
| Sep 30, 2025 | -5.81 Mn |
| Sep 30, 2025 | -5.81 Mn |
| Jun 30, 2025 | -5.31 Mn |
| Jun 30, 2025 | -5.31 Mn |
| Mar 31, 2025 | -5.65 Mn |
| Mar 31, 2025 | -5.65 Mn |
| Dec 31, 2024 | -954,404.00 |
| Dec 31, 2024 | -954,404.00 |
| Sep 30, 2024 | -3.09 Mn |
| Sep 30, 2024 | -3.09 Mn |
| Jun 30, 2024 | -318,203.00 |
| Jun 30, 2024 | -318,203.00 |
| Mar 31, 2024 | 145,747.00 |
| Mar 31, 2024 | 145,747.00 |